Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D, Zaidi AH, Martin SA, Omstead AN, Kosovec JE, Huleihel L, Saldin LT, DiCarlo C, Silverman JF, Hoppo T, Finley GG, Badylak SF, Kelly RJ, Jobe BA.
Matsui D, et al. Among authors: hoppo t.
Oncotarget. 2016 Dec 6;7(49):81281-81291. doi: 10.18632/oncotarget.12832.
Oncotarget. 2016.
PMID: 27793030
Free PMC article.
Review.